For instance, Ren et al. developed an immune-related signature consisting of four genes (MAGED1, ACKR3, FZD2, and CTLA4), highlighting the promising performance of immune-related signatures in GC treatment and prognosis prediction. This evidence concerns the gene FZD2 and gastric cancer.